These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 26859237)

  • 21. COVID-19 vaccine policy development in a sample of 44 countries - Key findings from a December 2021 survey of National Immunization Technical Advisory Groups (NITAGs).
    Kahn AL; Steffen CA; Henaff L; MacDonald NE; Morgan C; Faden R; Olayinka F; Desai S
    Vaccine; 2023 Jan; 41(3):676-683. PubMed ID: 36494252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. National immunization technical advisory groups (NITAGs) in the WHO Eastern Mediterranean Region (EMR): A decade of shaping immunization policies, 2010-2021.
    Etapelong Sume G; Quamrul H; Md S; Kissa J; Hutin Y
    Vaccine; 2024 Jan; 42(3):629-635. PubMed ID: 38143199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of National Immunization Technical Advisory Groups (NITAG) in strengthening health system governance: Lessons from three middle-income countries-Argentina, Jordan, and South Africa (2017-2018).
    Panero MS; Khuri-Bulos N; Biscayart C; Bonvehí P; Hayajneh W; Madhi SA
    Vaccine; 2020 Oct; 38(45):7118-7128. PubMed ID: 32950303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strengthening vaccination frameworks: Findings of a study on the legal foundations of National Immunization Technical Advisory Groups (NITAGs).
    Harmon SHE; Faour D; MacDonald NE; Graham J; Steffen C; Henaff L; Shendale S
    Vaccine; 2020 Jan; 38(4):840-846. PubMed ID: 31706811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characteristics and practices of National Immunisation Technical Advisory Groups in Europe and potential for collaboration, April 2014.
    Takla A; Wichmann O; Carrillo-Santisteve P; Cotter S; Levy-Bruhl D; Paradowska-Stankiewicz I; Valentiner-Branth P; D'Ancona F;
    Euro Surveill; 2015 Mar; 20(9):. PubMed ID: 25764188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.
    Blau J; Hoestlandt C; D Clark A; Baxter L; Felix Garcia AG; Mounaud B; Mosina L
    Vaccine; 2015 May; 33 Suppl 1():A34-9. PubMed ID: 25919171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overlapping topics in advisory reports issued by five well-established European National Immunization Technical Advisory Groups from 2011 to 2014.
    Nijsten D; Houweling H; Durupt A; Adjagba A
    Vaccine; 2016 Dec; 34(50):6200-6208. PubMed ID: 27836436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Building immunization decision-making capacity within the World Health Organization European Region.
    Mosina L; Sankar Datta S; Shefer A; Cavallaro KF; Henaff L; Steffen CA; Jacques-Carroll L
    Vaccine; 2020 Jul; 38(33):5109-5113. PubMed ID: 32563604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of NITAG policies and working processes in selected developed countries.
    Ricciardi GW; Toumi M; Weil-Olivier C; Ruitenberg EJ; Dankó D; Duru G; Picazo J; Zöllner Y; Poland G; Drummond M
    Vaccine; 2015 Jan; 33(1):3-11. PubMed ID: 25258100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Supporting National Immunization Technical Advisory Groups in the WHO European Region in developing national COVID-19 vaccination recommendations through online communication platform.
    Mosina L; Külper-Schiek W; Jacques-Carroll L; Earnshaw A; Harder T; Martinón-Torres F; Wilder-Smith A; Wichmann O; Datta SS
    Vaccine; 2021 Oct; 39(45):6595-6600. PubMed ID: 34629208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The French Technical Vaccination Committee (CTV).
    Floret D; Deutsch P
    Vaccine; 2010 Apr; 28 Suppl 1():A42-7. PubMed ID: 20412996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Supporting National Immunization Technical Advisory Groups (NITAGs) in development of evidence-based vaccine recommendations and NITAG assessments - New tools and approaches.
    Hadler SC; Shefer AM; Cavallaro KF; Ebama M; Tencza C; Kennedy ED; Ndiaye S; Shah A; Torre L; Bresee JS
    Vaccine; 2024 Jan; ():. PubMed ID: 38267328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The need for sustainability and alignment of future support for National Immunization Technical Advisory Groups (NITAGs) in low and middle-income countries.
    Howard N; Bell S; Walls H; Blanchard L; Brenzel L; Jit M; Mounier-Jack S
    Hum Vaccin Immunother; 2018 Jun; 14(6):1539-1541. PubMed ID: 29470931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global Advisory Group: conclusions and recommendations.
    Pan American Health Organization PAHO. Expanded Program on Immunization EPI. Global Advisory Group
    EPI Newsl; 1986 Feb; 13(1):4-6. PubMed ID: 12314333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moroccan National Immunization Technical Advisory Group: a valuable asset for the national immunization program and the immunization agenda in the EMRO region.
    Jroundi I; Benazzouz M; Yahyane AH; Alaoui MT; El Omeiri N
    Hum Vaccin Immunother; 2021 Aug; 17(8):2788-2792. PubMed ID: 33989118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strengthening National Immunization Technical Advisory Groups in resource-limited settings: current and potential linkages with polio national certification committees.
    Greene SA; Anya BM; Asghar H; Chaudhri IA; Datta SD; Donadel ME; Kouadio KI; Shefer AM; Cavallaro KF
    Health Res Policy Syst; 2020 Oct; 18(1):116. PubMed ID: 33023599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence-informed vaccination decision-making in countries: Progress, challenges and opportunities.
    Steffen CA; Henaff L; Durupt A; Omeiri NE; Ndiaye S; Batmunkh N; Liyanage JBL; Hasan Q; Mosina L; Jones I; O'Brien K; Hombach J
    Vaccine; 2021 Apr; 39(15):2146-2152. PubMed ID: 33712350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SMART Vaccines 2.0 decision-support platform: a tool to facilitate and promote priority setting for sustainable vaccination in resource-limited settings.
    McCormick BJJ; Waiswa P; Nalwadda C; Sewankambo NK; Knobler SL
    BMJ Glob Health; 2020 Nov; 5(11):. PubMed ID: 33239338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishment of a National Immunization Technical Advisory Group in Côte d'Ivoire: process and lessons learned.
    Blau J; Faye PC; Senouci K; Dagnan SN; Douba A; Saracino JT; Gessner BD
    Vaccine; 2012 Mar; 30(15):2588-93. PubMed ID: 22330125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.